Raymond James Financial’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$164K Buy
+14,720
New +$179K ﹤0.01% 5088
2025
Q3
– Sell
-9,153
Closed -$162K – 5210
2025
Q2
$162K Buy
+9,153
New +$178K ﹤0.01% 4618
2025
Q1
– Sell
-10,595
Closed -$196K – 4830
2024
Q4
$196K Buy
+10,595
New +$204K ﹤0.01% 4410

Other funds holding BTAL

Raymond James Financial's BTAL Position: Q2 2026 in Review

Raymond James Financial opened a new position in AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2026: 14,720 shares worth $164K. The stake represents ﹤0.01% of the portfolio and ranks #5088 among its holdings. This is a return to the name: Raymond James Financial previously reported a position in BTAL as recently as Q2 2025.

Raymond James Financial first reported a position in BTAL in Q4 2024 and has held it in 3 quarters since. The position peaked at $196K in Q4 2024. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • Raymond James Financial held 14,720 shares of AGF US Market Neutral Anti-Beta Fund worth $164K as of Q2 2026.
  • AGF US Market Neutral Anti-Beta Fund was a new Raymond James Financial position in Q2 2026.
  • AGF US Market Neutral Anti-Beta Fund made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #5088 holding.
  • Raymond James Financial first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2024 and has held it in 3 quarters since.
  • Raymond James Financial's AGF US Market Neutral Anti-Beta Fund position peaked at $196K in Q4 2024.
  • 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.